Seelos Therapeutics, Inc. Comprehensive Income
Seelos Therapeutics, Inc. reported Comprehensive Income of -$19.60 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-11-10
- Seelos Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$19.60M.
- Seelos Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was -$21.27M.
- Seelos Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$10.81M.
- Seelos Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-06-30 was -$8.86M.
- Seelos Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was -$21.79M.
- Seelos Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2013 was -$16.94M.
- Seelos Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2012 was -$31.13M.
- Seelos Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was -$18.12M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2022-09-30 | -$19.60M 10-Q · filed 2022-11-10 | -$40.88M derived: sum of 2 quarters · filed 2022-11-10 | -$54.88M 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | -$21.27M 10-Q · filed 2022-08-05 | -$35.27M 10-Q · filed 2022-08-05 | ||||
| 2021-09-30 | -$10.81M 10-Q · filed 2022-11-10 | -$19.67M derived: sum of 2 quarters · filed 2022-11-10 | -$38.79M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | -$8.86M 10-Q · filed 2022-08-05 | -$27.97M 10-Q · filed 2022-08-05 | ||||
| 2014-12-31 | -$21.79M 10-K · filed 2015-03-16 | |||||
| 2014-03-31 | -$3.26M 10-Q · filed 2014-05-12 | -$4.61M derived: sum of 2 quarters · filed 2015-03-16 | -$7.59M derived: sum of 3 quarters · filed 2015-03-16 | -$11.53M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$4.33M derived: sum of 2 quarters · filed 2015-03-16 | -$8.27M derived: sum of 3 quarters · filed 2015-03-16 | -$16.94M 10-K · filed 2015-03-16 | ||
| 2013-09-30 | -$2.98M 10-Q · filed 2013-11-12 | -$6.92M derived: sum of 2 quarters · filed 2013-11-12 | -$15.59M 10-Q · filed 2013-11-12 | -$34.55M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | -$3.94M 10-Q · filed 2013-08-14 | -$12.61M 10-Q · filed 2013-08-14 | -$31.56M derived: sum of 3 quarters · filed 2015-03-16 | -$34.02M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | -$8.60M 10-Q · filed 2014-05-12 | -$27.63M derived: sum of 2 quarters · filed 2015-03-16 | -$30.09M derived: sum of 3 quarters · filed 2015-03-16 | -$35.01M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | -$19.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$21.49M derived: sum of 2 quarters · filed 2015-03-16 | -$26.42M derived: sum of 3 quarters · filed 2015-03-16 | -$31.13M 10-K · filed 2015-03-16 | ||
| 2012-09-30 | -$2.46M 10-Q · filed 2013-11-12 | -$2.46M 10-Q · filed 2012-11-08 | -$7.38M derived: sum of 2 quarters · filed 2013-11-12 | -$12.10M 10-Q · filed 2013-11-12 | -$12.10M 10-Q · filed 2012-11-08 | -$16.79M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$4.93M 10-Q · filed 2013-08-14 | -$9.64M 10-Q · filed 2013-08-14 | -$14.33M derived: sum of 3 quarters · filed 2014-03-17 | -$16.55M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | -$4.71M 10-Q · filed 2013-05-10 | -$9.40M derived: sum of 2 quarters · filed 2014-03-17 | -$11.62M derived: sum of 3 quarters · filed 2014-03-17 | |||
| 2011-12-31 | -$4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$6.91M derived: sum of 2 quarters · filed 2014-03-17 | -$18.12M 10-K · filed 2014-03-17 | |||
| 2011-09-30 | -$2.22M 10-Q · filed 2012-11-08 | -$13.43M 10-Q · filed 2012-11-08 | ||||
| 2010-12-31 | -$29.51M 10-K · filed 2013-03-18 |